WHO ICTRP trial
Exploratory Clinical Study on Mifepristone for the Treatment of Recurrent…
ChiCTR2200065595 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200065595 |
|---|---|
| Public title | Exploratory Clinical Study on Mifepristone for the Treatment of Recurrent Glioblastoma |
| Scientific title | Phase I Clinical Trials on Mifepristone for the Treatment of Recurrent Glioblastoma |
| Primary sponsor | Huashan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Recurrent Glioblastoma |
| Interventions | treatment group:Administration of Mifepristone |
| Registration date | Nov 9, 2022 |
| Target size | treatment group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: